November 20, 2017 5:57 PM ET

Biotechnology

Company Overview of Inivata Limited

Key Executives for Inivata Limited

NameBoard RelationshipsTitleAge
Michael T. Stocum MS12 RelationshipsChief Executive Officer and Director--
James Brenton 3 RelationshipsScientific Founder52
Tim Forshew No RelationshipsScientific Founder--
Davina Gale No RelationshipsScientific Founder and Head of Molecular Diagnostics--
Nitzan Rosenfeld 8 RelationshipsScientific Founder, Chief Scientific Officer and Director--
View More Key Executives

Inivata Limited Board Members*

NameBoard RelationshipsPrimary CompanyAge
Jeffrey H. Buchalter BS, MBA 37 RelationshipsMolecular Partners AG60
Michael T. Stocum MS 12 RelationshipsInivata Limited--
Nitzan Rosenfeld 8 RelationshipsInivata Limited--
Keith Blundy Ph.D., MBA 27 RelationshipsStorm Therapeutics Limited--
Jeanne Bolger M.D., MB BCh BAO 22 RelationshipsJohnson & Johnson Innovation - JJDC, Inc.57
View All Board Members

Inivata Limited Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
388.9K
Bonus
242.6K
Total Short Term Compensation
485.8K
Total Value of Options
17.8M
Compensation as of Fiscal Year
Inivata Limited CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Denis Wad to Resign as Director of Biotron Limited
November 20, 2017 12:17 AM ET
Humanigen, Inc. Announces Executive Changes
November 16, 2017 10:03 PM ET
Novelion Therapeutics Inc. Announces Board Appointments
November 16, 2017 9:02 PM ET
Premier Biomedical Appoints Carl Eller as Marketing & Planning Vice-President
November 16, 2017 3:00 PM ET
Gt Biopharma, Inc. Appoints Shawn M. Cross as President and Chief Operating Officer
November 16, 2017 1:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inivata Limited, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.